Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation.

Y, Matsumura-Nakano; S, Shizuta; A, Komasa; T, Morimoto; H, Masuda; H, Shiomi; K, Goto; K, Nakai; H, Ogawa; A, Kobori; Y, Kono; K, Kaitani; S, Suwa; T, Aoyama; M, Takahashi; Y, Sasaki; Y, Onishi; T, Mano; M, Matsuda; M, Motooka; H, Tomita; M, Inoko; T, Wakeyama; N, Hagiwara; K, Tanabe; M, Akao; K, Miyauchi; J, Yajima; K, Hanaoka; Y, Morino; K, Ando; Y, Furukawa; Y, Nakagawa; K, Nakao; K, Kozuma; K, Kadota; K, Kimura; K, Kawai; T, Ueno; K, Okumura; T, Kimura

doi:10.1161/circulationaha.118.036768

Public

Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation.

Shared by NobleBlocks on Jan 1, 2019 • 12:00 AM UTC

Authors:

Matsumura-Nakano Y

Shizuta S

Komasa A

Abstract

<h4>Background</h4>Despite recommendations in the guidelines and consensus documents, there has been no randomized controlled trial evaluating oral anticoagulation (OAC) alone without antiplatelet therapy (APT) in patients with atrial fibrillation and stable coronary artery disease beyond 1 year aft...

Subject

Atrial fibrillation

Percutaneous coronary intervention

coronary artery disease

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!